Oxidative stress and antioxidant parameters in neutropenic patients secondary to chemotherapy
Pakistan Journal of Medical Sciences. 2016; 32 (2): 309-313
en Inglés
| IMEMR
| ID: emr-178636
ABSTRACT
Objective:
Neutropenia is a serious adverse event that necessitates dosage reduction in patients receiving chemotherapy. In this study, we evaluated the oxidative stress and antioxidant parameters in neutropenic patients after chemotherapy both during the neutropenic period and after successful treatment of neutropenia with filgrastim
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Idioma:
Inglés
Revista:
Pak. J. Med. Sci.
Año:
2016
Similares
MEDLINE
...
LILACS
LIS